3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
5
Rhabdoid Tumor
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Neuroblastoma
5
Medulloblastoma
5
Lymphoma, Non-Hodgkin
5
Histiocytosis, Langerhans-Cell
5
Hepatoblastoma
5
Glioma
5
Ependymoma
5
Sarcoma
4
Rhabdomyosarcoma
4
Osteosarcoma
4
Central Nervous System Neoplasms
4
Sarcoma, Ewing
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroendocrine Tumors
2
Lung Neoplasms
2
Burkitt Lymphoma
2
Xanthogranuloma, Juvenile
1
Pancreatic Neoplasms
1
Pancreatic Intraductal Neoplasms
1
Non functioning pancreatic endocrine tumor
1
Neoplasm Metastasis
1
Lymphoma, B-Cell
1
Lymphoma
1
Histiocytic Sarcoma
1
Familial ependymoma
1
Carcinoma, Non-Small-Cell Lung
1
Adenoma, Islet Cell
1
Interventions
Cisplatin
4
pembrolizumab
3
Nivolumab
3
Fluorouracil
2
Carboplatin
2
toripalimab
1
spartalizumab
1
fludarabine phosphate
1
fludarabine
1
cc-486
1
camrelizumab
1
Vorinostat
1
Valganciclovir
1
Range of Motion, Articular
1
Radiotherapy
1
Radiosurgery
1
Protons
1
Platinum
1
Methylprednisolone
1
Medicare Part B
1
Laryngoscopes
1
Gemcitabine
1
Docetaxel
1
Cyclophosphamide
1
Cetuximab
1
Bevacizumab
1
Azacitidine
1
Adrenal Cortex Hormones
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Nasopharyngeal Carcinoma
×
Phantoms, Imaging
×
Clear all
No trials found.